| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 3, 2006
Accepted on August 11, 2006
Department of Pediatrics, Division of Endocrinology, Campus Box #7039, 3341 MBRB, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7039
* To whom correspondence should be addressed. E-mail: ajd{at}med.unc.edu.
Insulin-like growth factor-l (IGF-I) is essential to normal brain growth, and exerts actions on neural stem cells and each major neural cell lineage. While many studies show that IGF-I regulates gene expression, mechanisms by which it modulates transcription have not been explored. Chromatin modification, such as histone phosphorylation, acetylation and methylation, are known to be important initial steps in gene regulation, and acetylation of histone H3 and H4 are associated with gene activation. In this study, we show that IGF-I modulates the acetylation of H3 and H4 histones in the brain of two transgenic mouse lines and that these effects are associated with activation of the PI3-kinase/Akt signaling pathway. This provides evidence that the chromatin architecture modification contributes to the action of IGF-I on gene expression in the mammalian CNS.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |